Notice2024-02636
Meeting of the National Vaccine Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 9, 2024
Issuing agencies
Health and Human Services Department
Abstract
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) hereby gives notice that the National Vaccine Advisory Committee (NVAC) will hold an in-person meeting. The meeting will be open to the public and public comment will be heard during the meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 28 (Friday, February 9, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 28 (Friday, February 9, 2024)]
[Notices]
[Pages 9163-9164]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02636]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) hereby gives notice that
the National Vaccine Advisory Committee (NVAC) will hold an in-person
meeting. The meeting will be open to the public and public comment will
be heard during the meeting.
DATES: The meeting will be held February 22-23, 2024. The confirmed
meeting times and agenda will be posted on the NVAC website at <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a> as soon as they become
available.
ADDRESSES: Instructions regarding attending this meeting will be posted
online at: <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a> at least
one week prior to the meeting. Pre-registration is required for those
who wish to attend the meeting in person or participate in public
comment. Please register at <a href="http://www.hhs.gov/nvpo/nvac/meetings/index.html">http://www.hhs.gov/nvpo/nvac/meetings/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal
Officer, Office of Infectious Disease and HIV/AIDS Policy, U.S.
Department of Health and Human Services, Tower Building, Room, 1101
Wootton Parkway, Rockville, MD 20852. Email: <a href="/cdn-cgi/l/email-protection#4e20382f2d0e26263d60292138"><span class="__cf_email__" data-cfemail="751b031416351d1d065b121a03">[email protected]</span></a>. Phone: 202-
795-7697.
SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public
Health
[[Page 9164]]
Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was mandated to
establish the National Vaccine Program to achieve optimal prevention of
human infectious diseases through immunization and to achieve optimal
prevention against adverse reactions to vaccines. The NVAC was
established to provide advice and make recommendations to the Director
of the National Vaccine Program on matters related to the Program's
responsibilities. The Assistant Secretary for Health serves as Director
of the National Vaccine Program.
During this meeting, NVAC will hear presentations to support the
recent charge on innovation from Admiral Rachel L. Levine, MD, the
Assistant Secretary for Health and Director of the National Vaccine
Program. NVAC will also hear presentations on recent surges in measles
cases, the Vaccines for Children's Program, real uses of artificial
intelligence to support vaccination efforts, and supply chains.
Presenters will also cover ways to improve immunization of children,
adults, and pregnant people. Please note that agenda items are subject
to change, as priorities dictate. Information on the final meeting
agenda will be posted prior to the meeting on the NVAC website: <a href="http://www.hhs.gov/nvpo/nvac/index.html">http://www.hhs.gov/nvpo/nvac/index.html</a>.
Members of the public will have the opportunity to provide comment
at the NVAC meeting during the public comment period designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Members of the public may also submit written
comments. Written comments should not exceed three pages in length.
Individuals planning to submit comments should email their written
comments or their request to provide a comment during the meeting to
<a href="/cdn-cgi/l/email-protection#2c425a4d4f6c44445f024b435a"><span class="__cf_email__" data-cfemail="78160e191b3810100b561f170e">[email protected]</span></a> at least five business days prior to the meeting.
Dated: January 11, 2024.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary
for Health.
[FR Doc. 2024-02636 Filed 2-8-24; 8:45 am]
BILLING CODE 4150-44-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 9, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.